Author Question: An economist encounters some unexpected behavior in a market or laboratory setting. How can he or ... (Read 44 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
An economist encounters some unexpected behavior in a market or laboratory setting. How can he or she distinguish between behavior resulting from mistakes by decision makers as opposed to being decisions based on unusual preferences?
 a. If the same behavior is observed repeatedly even after opportunities to learn are provided, it is probably not a mistake.
  b. If the behavior is observed more often with inexperienced subjects, it is likely a mistake.
  c. Both a and b.
  d. It is impossible to distinguish between mistakes and unusual preferences empirically.

Question 2

Limits to self-interested payoff maximization that have been studied by behavioral economists include
 a. limited cognitive ability.
  b. limited willpower.
  c. limits to self interest.
  d. all of the above.



tandmlomax84

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

c

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library